
Microsoft has not offered any remedies to EU antitrust regulators reviewing its proposed $69 billion bid for “Call of Duty” maker Activision Blizzard ahead of an expected full-scale EU probe, reported Reuters.
The US software company is betting on the acquisition to help it compete better with leaders Tencent and Sony, with the latter being a critic of the deal.
The European Commission, which is scheduled to finish its preliminary assessment of the deal by Nov. 8, said its website was up to date. The site showed that Microsoft had not provided concessions.
Related: EU Wants To Know If Microsoft Will Block Rivals After Activision Blizzard Buy
Microsoft said it continues to work with the Commission on the next steps and to address any valid marketplace concerns, such as those voiced by Sony.
“Sony, as the industry leader, says it is worried about Call of Duty, but we’ve said we are committed to making the same game available on the same day on both Xbox and PlayStation,” Microsoft said in a statement.
Companies typically do not offer remedies during the EU preliminary review when they know regulators subsequently intend to open a four-month long investigation.
Featured News
Italy Fines AI Chatbot Maker Replika €5 Million Over Privacy Violations
May 19, 2025 by
CPI
Germany’s Antitrust Chief: EU-US Tech Policy Divide Is Mostly Rhetoric
May 19, 2025 by
CPI
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas